Sampre Nutritions Limited (BOM:530617)
India flag India · Delayed Price · Currency is INR
4.920
-0.250 (-4.84%)
At close: Jul 31, 2026

Sampre Nutritions Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
433.47433.47251.24251.47371.07231.26
Revenue Growth
72.53%72.53%-0.09%-32.23%60.46%26.83%
Gross Profit
284.37284.3721.4885.3783.2563.92
Operating Income
27.1227.12-58.3422.9222.3418.84
Net Income
30.7730.77-76.722.323.473.08
Earnings Per Share
0.360.36-1.360.080.090.16
EPS Growth
----8.89%-42.06%306.61%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.820.822.322.851.260.83
Total Debt
179.1179.1169.04175167.71212.33
Net Cash (Debt)
-178.28-178.28-166.72-172.16-166.45-211.51
Net Cash Growth
------
Net Cash Per Share
-2.12-2.12-2.95-6.26-4.43-10.97

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-10.97-10.970.8439.528.7924.09
Capital Expenditures
-22.86-22.86-2.77-37.09-44.06-13.02
Free Cash Flow
-33.83-33.83-1.932.44-35.2711.07
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
65.60%65.60%8.55%33.95%22.44%27.64%
Operating Margin
6.26%6.26%-23.22%9.11%6.02%8.15%
Pretax Margin
4.10%4.10%-29.95%1.94%1.13%1.61%
Profit Margin
7.10%7.10%-30.54%0.92%0.94%1.33%
FCF Margin
-7.80%-7.80%-0.77%0.97%-9.51%4.79%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
13.4849.17-213.86180.4750.97
P/FCF Ratio
---203.16-14.18
PS Ratio
0.993.491.881.971.690.68